Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.61 |
| ▸ | MAPT | P10636 | 5/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | TTR | P02766 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | ELANE | P08246 | 1/20 | 0.52 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.51 |
| ▸ | TUBB | P07437 | 1/20 | 0.51 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.51 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.51 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.51 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL3155393 | 0.96 | KMT2A (0.59) | KMT2AMAPTKDM4ELMNAMEN1 | |
| SCHEMBL6790494 | 0.94 | HSD17B10 (0.59) | KMT2AMAPTKDM4ELMNAMEN1 | |
| SCHEMBL7013877 | 0.92 | ELANE (0.65) | KMT2AMAPTKDM4ELMNAMEN1 | |
| 4-Hydroxybenzaldehyde SCHEMBL9418057 | 0.92 | ALDH5A1 (0.59) | KMT2AMAPTKDM4ELMNAMEN1 | |
| SCHEMBL8009088 | 0.89 | ALDH1A1 (0.58) | KMT2AMAPTKDM4ELMNAMEN1 | |
| SCHEMBL11354408 | 0.84 | MAPT (0.81) | KMT2AMAPTKDM4ELMNAMEN1 | |
| SCHEMBL6243024 | 0.84 | KMT2A (0.60) | KMT2AMAPTKDM4ELMNAMEN1 | |
| SCHEMBL10941162 | 0.84 | MAPT (0.81) | KMT2AMAPTKDM4ELMNAMEN1 | |
| SCHEMBL2451780 | 0.84 | MAPT (0.81) | KMT2AMAPTKDM4ELMNAMEN1 | |
| SCHEMBL269329 | 0.83 | LMNA (0.80) | KMT2AMAPTKDM4ELMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 687 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230391828-A1 | REGULATORS OF CELL DIVISION | TECHNISCHE UNIVERSITAT DRESDEN (DE) | 2023-12-07 | — | — | US | claimed |
| EP-4225780-A2 | REGULATORS OF CELL DIVISION | Technische Universität Dresden (DE) | 2023-08-16 | — | — | EP | claimed |
| CN-113336645-B | Method for synthesizing p-acetoxystyrene by one-pot method | 上海博栋化学科技有限公司 | 2023-06-27 | — | — | CN | claimed |
| US-20230118467-A1 | COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE L | SYMRISE AG (DE) | 2023-04-20 | — | — | US | claimed |
| EP-4114353-A1 | COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE L | Symrise AG (DE) | 2023-01-11 | — | — | EP | claimed |
| CN-113527236-B | Method for preparing amiodarone hydrochloride | 苏州弘森药业股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| WO-2022074072-A2 | REGULATORS OF CELL DIVISION | Technische Universität Dresden (DE) | 2022-04-14 | — | — | WO | claimed |
| CN-109438326-B | Fluorescent probe for detecting carboxylesterase, preparation method thereof and special detection kit | 潍坊医学院 | 2022-02-15 | — | — | CN | claimed |
| CN-113336645-A | Method for synthesizing p-acetoxystyrene by one-pot method | 上海博栋化学科技有限公司 | 2021-09-03 | — | — | CN | claimed |
| CN-107722146-B | Method for producing solid polyaluminoxane composition | 三井化学株式会社 | 2021-02-26 | — | — | CN | claimed |
| WO-2003022860-A1 | SYNTHETIC HEPARIN PENTASACCHARIDES | ALCHEMIA PTY LTD (AU) | 2003-03-20 | — | — | WO | claimed |
| WO-2002083123-A1 | AURONES AS TELOMERASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2002-10-24 | — | — | WO | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| US-5663022-A | Recording sheets | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0674232-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-5002699-A | Electrically conducting polymers and complexes | HONEYWELL INC. (US) | 1991-03-26 | — | — | US | claimed |
| US-4483861-A | Antihypertensive sulfur-containing compounds | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1984-11-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230118467-A1 | COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE L | TACR1, NPSR1, TACR2 | KMT2A 2632/4885MAPT 991/4885KDM4E 4589/4885 |
| US-20230391828-A1 | REGULATORS OF CELL DIVISION | PCNA, BOD1L1, MKI67 | KMT2A 3967/4885MAPT 4162/4885KDM4E 3982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.